Please login to the form below
Daito
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.
Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
Teva will lead commercialisation of the product in Europe, Israel and specified other countries, while Sanofi will lead commercialisation in North America, Japan, other parts of Asia and the rest of
Cancer Research UK partners with French cancer institute
In May, the INCa joined the G7 Cancer Initiative alongside six other international organisations, including Cancer Research UK, in Australia, Canada, Germany, Japan and the US.
BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody
in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia. ... general manager at BMS, Japan.
eCTD 4.0 is changing the regulatory landscape – what you need to know
CVs for application, submission and submission unit type CVs are relevant for the US, the EU and Japan. ... CV for category event submission type is relevant for Japan, and not for the US or the EU.
Bristol Myers Squibb’s Opdivo approved by EC for expanded melanoma use
The therapy is currently approved in more than 65 countries, including the US, EU, Japan and China, for a range of indications such as lung, kidney and gastric cancers.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
